Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
BP
BP
$110B
| $1.76M | ﹤0.01% |
64,555
+54,620
| +550% | +$1.37M |
|
4027
Mustang Bio
MBIO
$4.5M
| $1.76M | ﹤0.01% |
872
+5
| +0.6% | +$10.7K |
|
4028
DXP Enterprises
DXPE
$2.65B
| $1.76M | ﹤0.01% |
59,459
+44,926
| +309% | +$1.38M |
|
4029
CALL
Community Health Systems
CYH
$417M
| $1.75M | ﹤0.01% |
150,000
-150,000
| -50% | -$1.96M |
|
4030
Hasbro
HAS
$12.9B
| $1.75M | ﹤0.01% |
19,671
-184,468
| -90% | -$17.9M |
|
4031
Consolidated Edison
ED
$40B
| $1.75M | ﹤0.01% |
24,166
-31,682
| -57% | -$2.37M |
|
|
BNR
4032
Burning Rock Biotech
BNR
$96.1M
| $1.75M | ﹤0.01% |
+9,802
| New | +$2.18M |
|
4033
Opko Health
OPK
$985M
| $1.75M | ﹤0.01% |
479,760
+45,896
| +11% | +$171K |
|
|
SHCO
4034
DELISTED
Soho House & Co
SHCO
| $1.75M | ﹤0.01% |
+140,555
| New | +$1.76M |
|
4035
PUT
Boston Properties
BXP
$11.3B
| $1.74M | ﹤0.01% |
+16,100
| New | +$1.84M |
|
4036
PUT
Idexx Laboratories
IDXX
$46.3B
| $1.74M | ﹤0.01% |
2,800
-5,000
| -64% | -$3.36M |
|
4037
Quantum-Si Incorporated
QSI
$170M
| $1.74M | ﹤0.01% |
208,722
-2,541,278
| -92% | -$25M |
|
4038
CALL
MannKind Corp
MNKD
$1.22B
| $1.74M | ﹤0.01% |
+400,000
| New | +$1.8M |
|
4039
Century Therapeutics
IPSC
$364M
| $1.74M | ﹤0.01% |
69,024
-112,140
| -62% | -$3.04M |
|
4040
Kadant
KAI
$3.95B
| $1.74M | ﹤0.01% |
8,502
+3,243
| +62% | +$639K |
|
|
AD
4041
Array Digital Infrastructure
AD
$3.07B
| $1.73M | ﹤0.01% |
54,379
-33,629
| -38% | -$1.12M |
|
|
MDWT
4042
DELISTED
Midwest Holding Inc. Common Stock
MDWT
| $1.73M | ﹤0.01% |
44,554
-11,233
| -20% | -$436K |
|
4043
International Money Express
IMXI
$370M
| $1.73M | ﹤0.01% |
+103,676
| New | +$1.74M |
|
4044
National Grid
NGG
$80.8B
| $1.73M | ﹤0.01% |
+32,819
| New | +$1.88M |
|
4045
CALL
Seer Inc
SEER
$122M
| $1.73M | ﹤0.01% |
50,000
-50,000
| -50% | -$1.72M |
|
4046
Sherwin-Williams
SHW
$87.7B
| $1.73M | ﹤0.01% |
6,174
-304,424
| -98% | -$89.1M |
|
|
ZENV
4047
DELISTED
Zenvia
ZENV
| $1.72M | ﹤0.01% |
+125,138
| New | +$1.79M |
|
4048
Ring Energy
REI
$317M
| $1.72M | ﹤0.01% |
+583,184
| New | +$1.49M |
|
|
CSGS
4049
DELISTED
CSG Systems International
CSGS
| $1.72M | ﹤0.01% |
35,637
-37,090
| -51% | -$1.74M |
|
4050
InterDigital
IDCC
$8.34B
| $1.72M | ﹤0.01% |
25,330
+5,248
| +26% | +$364K |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.